Open AccessNo mortality difference following treatment with terlipressin or somatostatin in cirrhotic patients with gastric variceal hemorrhage
Author(s) -
Tsung–Hsing Hung,
Chen–Chi Tsai,
Guo-Chih TsenK,
YuHsi Hsieh,
ChihWei Tseng
Publication year - 2016
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.182458
Subject(s) - medicine , terlipressin , octreotide , cirrhosis , gastroenterology , sclerotherapy , hepatic encephalopathy , gastric varices , somatostatin , portal hypertension , mortality rate , surgery , hepatorenal syndrome
The aim of this study was to compare the efficacy of terlipressin versus somatostatin as adjuvants to endoscopic treatment in cirrhotic patients with gastric variceal bleeding.